Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-31 @ 7:17 PM
Study NCT ID:
NCT01491633
Status:
TERMINATED
Last Update Posted:
2014-07-15
First Post:
2011-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dasatinib in Advanced Squamous Cell Lung Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
11-142
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None